EDGAR ENGLEMAN

Profile

First Name

: EDGAR

Middle Name

:

Last Name

: ENGLEMAN

Related Companies
Titles
Company Name
Related People
DIRECTOR
CAPNIA, INC.
WILLIAM JAMES ALEXANDER, ANISH BHATNAGAR, STUART COLLINSON, GARY CROOKE, GRAHAM K. CROOKE, RAJEN DALAL, STEINAR ENGELSEN, STEINAR J ENGELSEN, STEINAR J. ENGELSEN, EDGAR G. ENGLEMAN, WILLIAM HARRIS, WILLIAM G. HARRIS, STEPHEN N KIRNON, STEPHEN N. KIRNON, JAMES MACKANESS, ERNEST MARIO, GWEN MELINCOFF, DAVID D. O-TOOLE, MATTHEW PAULS, GINA PHELPS, MAHENDRA SHAH, ANDREW SINCLAIR, BIRGITTE VOLCK, JONATHAN D. WOLTER, ANTHONY WONDKA
DIRECTOR
VIVO VENTURES VII AFFILIATES FUND, L.P.
ALBERT CHA, FRANK KUNG, N/A VIVO VENTURES VII, LLC
DIRECTOR
SEMNUR PHARMACEUTICALS, INC.
BRENT AHRENS, JAISIM SHAH, MAHENDRA G. SHAH, JAMES TOPPER
DIRECTOR
VIVO CAPITAL FUND VIII, L.P.
ALBERT CHA, FRANK KUNG, N/A VIVO CAPITAL VIII, LLC
DIRECTOR
VIVO CAPITAL SURPLUS FUND VIII, L.P.
ALBERT CHA, FRANK KUNG, N/A VIVO CAPITAL VIII, LLC
DIRECTOR
VIVO CAPITAL FUND IX, L.P.
ALBERT CHA, SHAN FU, FRANK KUNG, N/A VIVO CAPITAL IX, LLC, CHEN YU
DIRECTOR, EXECUTIVE OFFICER
BOLT BIOTHERAPEUTICS, INC.
PETER BISGAARD, DAVID DORNAN, EDGAR G ENGLEMAN, EDGAR G. ENGLEMAN, KEN HARRISON, JAMES HEALY, ASHISH KHANNA, KATHLEEN LAPORTE, REINER LAUS, CHIH-PING LIU, RICHARD MILLER, PETER MOLDT, EDITH PEREZ, WILLIAM QUINN, RANDALL SCHATZMAN, MAHENDRA SHAH, GRANT YONEHIRO
DIRECTOR
VIVO INNOVATION FUND II, L.P.
MICHAEL CHANG, LU HONGBO, FRANK KUNG, JACK NIELSEN, N/A VIVO INNOVATION II, LLC
DIRECTOR
VIVO CAPITAL FUND X, L.P.
GAURAV AGGARWAL, MICHAEL CHANG, SHAN FU, FRANK KUNG, DAVID LIU, N/A VIVO CAPITAL X, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-20
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-07-31 
2025-01-08
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-07-31 
2022-03-18
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2021-02-10 
2021-06-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-06-01 
2021-01-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-06-26 
2019-10-30
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-08-20 
2019-08-12
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-08-20 
2019-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2019-06-03
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-08-20 
2019-01-23
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-08-20 
2018-12-06
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-08-20 
2015-03-18
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-17 
2015-03-18
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-17 
2015-02-05
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-17 
2015-02-05
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-17 
2014-12-18
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-17 
2014-12-18
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-17 
2013-08-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-06 
2012-01-03
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2011-12-21 
2010-11-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-10 
2010-03-19
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2010-02-10 
2010-02-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2010-02-10